Amorelli, Giulia Maria
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 226
AS - Asia 59
AF - Africa 5
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 522
Nazione #
US - Stati Uniti d'America 224
SE - Svezia 62
IT - Italia 51
FR - Francia 19
IE - Irlanda 19
DE - Germania 18
SG - Singapore 17
IN - India 14
RU - Federazione Russa 13
MK - Macedonia 12
CN - Cina 11
RS - Serbia 8
FI - Finlandia 6
GB - Regno Unito 5
TR - Turchia 4
EG - Egitto 3
PE - Perù 3
BE - Belgio 2
CA - Canada 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
IR - Iran 2
KR - Corea 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
TW - Taiwan 2
UA - Ucraina 2
AT - Austria 1
DK - Danimarca 1
ES - Italia 1
HK - Hong Kong 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NL - Olanda 1
PL - Polonia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 522
Città #
Chandler 60
Ashburn 31
New York 22
Dublin 19
Milan 17
Rome 13
Marseille 12
Singapore 12
Skopje 10
Moscow 9
Mumbai 8
Niš 6
Princeton 6
Helsinki 5
Pune 5
Beijing 4
Boston 4
Bremen 4
Atlanta 3
Cairo 3
Cattolica 3
Lima 3
Munich 3
Ankara 2
Bari 2
Bauang 2
Brussels 2
Fairfield 2
Harrisburg 2
Lahore 2
Los Angeles 2
Novi Sad 2
Paris 2
Romainville 2
San Cesareo 2
San Mateo 2
Santa Clara 2
Shenzhen 2
Taipei 2
Washington 2
Wilmington 2
Andover 1
Augusta 1
Bern 1
Boardman 1
Brdo 1
Brno 1
Busto Arsizio 1
Caldaro sulla Strada del Vino 1
Central 1
Florence 1
Freiburg im Breisgau 1
Gaeta 1
Hangzhou 1
Kashan 1
Kish 1
Lappeenranta 1
Lausanne 1
London 1
Lviv 1
Macao 1
Madrid 1
Montreal 1
Mykolayiv 1
Naples 1
Nuremberg 1
Pristina 1
Pullach im Isartal 1
Reading 1
Redwood City 1
Royal Oak 1
Sanremo 1
Seattle 1
Secaucus 1
Seongnam-si 1
Seoul 1
Toronto 1
Vignanello 1
Warsaw 1
Watertown 1
Totale 337
Nome #
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 74
Early visual and neuro-development in preterm infants with and without retinopathy 70
Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings 52
Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab 49
Functional and morphologic findings at four years after intravitreal bevacizumab or laser for type 1 ROP 48
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 46
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 44
The role of retinal imaging in the management of abusive head trauma cases 43
Risdiplam in Type 1 Spinal Muscular Atrophy 35
Optic Disk Pit Maculopathy Treatment Using a Human Amniotic Membrane Patch: One-Year Results 34
Visual Function in Children with GNAO1-Related Encephalopathy 19
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study (Neurology and Therapy, (2023), 12, 2, (543-557), 10.1007/s40120-023-00444-1) 12
COVID-19 presenting as a non-arteritic anterior ischemic optic neuropathy 9
Totale 535
Categoria #
all - tutte 3.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 2 0 4 3 1 3 2
2021/202255 4 2 0 6 2 0 0 7 3 7 10 14
2022/2023260 24 35 13 32 12 23 15 15 59 7 13 12
2023/2024200 13 28 14 20 3 44 12 10 9 5 21 21
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 535